Because of the significant association between high AURKA expression and cancer progression, poor prognosis, and drug resistance, AURKA is a preferred target for anti-cancer strategies, especially the use of small molecule kinase inhibitors [4, 5] and targeted proteolytic tools [6, 7]. Here, AURKA is linked to cancer.